https://psychedelicstockreview.com/adding-ehave-ehvff-to-psychedelic-stock-watch-list/2021-08-21T11:34:00-04:00https://psychedelicstockreview.com/universe/2021-10-15T09:35:21-04:00https://psychedelicstockreview.com/ablepartners/2021-08-04T17:39:48-04:00https://psychedelicstockreview.com/cybin-clxpf-banks-30-million-overnight/2021-08-12T07:28:53-04:00https://psychedelicstockreview.com/incredible-ibogaine-psychedelics-testimonial/2024-01-22T14:14:17-05:00https://psychedelicstockreview.com/mindmed-mnmd/2021-08-05T15:07:36-04:00https://psychedelicstockreview.com/compass-pathways-cmps/2021-08-05T15:15:59-04:00https://psychedelicstockreview.com/atai-life-sciences-atai/2021-09-18T10:58:40-04:00https://psychedelicstockreview.com/horizons-psychedelic-index-etf/2021-09-29T10:08:58-04:00https://psychedelicstockreview.com/palo-santo/2021-08-04T17:38:17-04:00https://psychedelicstockreview.com/cybin-clxpf-gets-8-00-price-target-from-h-c-wainwright/2021-08-12T07:29:12-04:00https://psychedelicstockreview.com/psychedelic-investor-conferences/2021-08-04T17:45:43-04:00https://psychedelicstockreview.com/novemind-csenm-otcnvmdf-presentation-deck/2021-08-05T14:12:54-04:00https://psychedelicstockreview.com/side-stories/2021-09-14T07:26:31-04:00https://psychedelicstockreview.com/psychedelic-ipos-build-momentum-pitchbook/2021-08-07T15:29:14-04:00https://psychedelicstockreview.com/revive-therapeutics-rvvcn-rvvtf-approved-to-trade-on-the-otcqb-market/2021-08-08T11:30:22-04:00https://psychedelicstockreview.com/revive-therapeutics-rvvcn-rvvtf-presentation-deck/2021-08-08T13:51:30-04:00https://psychedelicstockreview.com/atai-life-sciences-atai-presentation-deck/2021-08-12T15:46:14-04:00https://psychedelicstockreview.com/10-psychedelic-startups-investors-are-flocking-to-insider-monkey/2021-08-09T07:03:38-04:00https://psychedelicstockreview.com/psychedelics-space-is-just-getting-started-field-trip-health-ftrp-chairman-ronan-levy/2021-08-11T07:20:22-04:00https://psychedelicstockreview.com/subscribe-for-free/2023-10-28T13:42:22-04:00https://psychedelicstockreview.com/2021-psychedelic-investor-guide/2023-09-22T04:40:09-04:00https://psychedelicstockreview.com/2021-psychedelic-investor-conference/2023-10-30T15:05:08-04:00https://psychedelicstockreview.com/filament-health-fh-ne-is-the-first-public-company-to-be-issued-a-patent-for-extraction-of-natural-psilocybin/2021-08-10T13:10:57-04:00https://psychedelicstockreview.com/biomind-labs-inc-completes-reverse-take-over-transaction/2021-08-11T07:08:03-04:00https://psychedelicstockreview.com/biomind-labs-bmnd-begins-trading-on-the-neo-exchange/2021-08-11T07:18:39-04:00https://psychedelicstockreview.com/revive-therapeutics-rvvtf-provides-update-on-psychedelics-clinical-product-pipeline/2021-08-11T10:07:17-04:00https://psychedelicstockreview.com/wonderland-miami/2021-08-11T10:53:02-04:00https://psychedelicstockreview.com/small-pharma-to-present-at-canaccord-genuitys-annual-growth-conference/2021-08-12T07:30:48-04:00https://psychedelicstockreview.com/telehealth-and-psychedelics-contactless-health-screening-from-ehave-ehvvf-and-vastminz/2021-08-12T11:53:52-04:00https://psychedelicstockreview.com/compass-pathways-cmps-2-report-2q-and-business-highlights/2021-08-12T15:16:27-04:00https://psychedelicstockreview.com/we-just-got-closer-to-understanding-why-ketamine-is-such-a-powerful-antidepressant-science-alert/2021-08-19T11:37:58-04:00https://psychedelicstockreview.com/video-business-tv-news/2021-08-20T15:34:25-04:00https://psychedelicstockreview.com/huge-news-at-ehave-inc-ehvvf-our-favorite-psychedelic/2021-09-15T12:24:57-04:00https://psychedelicstockreview.com/lobe-sciences-gtsif-provides-corporate-update-to-investors-and-stakeholders/2021-09-13T23:25:13-04:00https://psychedelicstockreview.com/neonmind-nmbdf-announces-divestiture-of-consumer-related-and-other-non-core-assets/2021-09-13T23:20:29-04:00https://psychedelicstockreview.com/ketamine-one-konef-signs-loi-for-two-ketamine-infusion-clinics-in-texas/2021-09-13T23:45:08-04:00https://psychedelicstockreview.com/ehave-ehvvf-announces-update-on-ehave-medical-app-with-the-launch-of-covid-vaccine-passport-going-live-shortly/2021-09-13T23:38:27-04:00https://psychedelicstockreview.com/scientists-studying-psychoactive-drugs-accidentally-proved-the-self-is-an-illusion-quartz/2021-09-14T07:58:09-04:00https://psychedelicstockreview.com/on-demand-now-life-sciences-psychedelic-presentations/2021-09-17T11:44:06-04:00https://psychedelicstockreview.com/atai-life-sciences-atai-increases-loan-in-principal-by-us6m-to-support-intelgenxs-graduation-to-the-tse/2021-09-20T13:29:10-04:00https://psychedelicstockreview.com/mydecine-innovations-group-mycof-announces-myco-001-seamless-phase-2-3-smoking-cessation-clinical-trial/2021-09-20T12:56:04-04:00https://psychedelicstockreview.com/novamind-nvmdf-announces-inclusion-in-nyse-listed-advisorshares-psychedelics-etf-psil/2021-09-21T08:47:09-04:00https://psychedelicstockreview.com/ketamine-one-signs-loi-with-veteran-services-usa-to-open-therapy-center/2021-09-21T13:10:46-04:00https://psychedelicstockreview.com/advisorshares-psychedelics-etf-psil/2021-09-21T12:52:09-04:00https://psychedelicstockreview.com/huge-news-on-opioid-addiction-from-atai-atai/2021-09-21T14:11:26-04:00https://psychedelicstockreview.com/advisorshares-launches-psychedelics-etf-ticker-psil/2021-09-21T14:47:48-04:00https://psychedelicstockreview.com/small-pharma-dmttf-successfully-completes-phase-i-clinical-trial-of-dmt-in-combination-with-supportive-psychotherapy/2021-09-21T16:32:39-04:00https://psychedelicstockreview.com/bright-minds-biosciences-bimbf-provides-scientific-update/2021-09-22T09:57:55-04:00https://psychedelicstockreview.com/greenbrook-tms-gnhh-announces-increase-to-bought-deal-financing-to-us11-5-million/2021-09-22T16:56:21-04:00https://psychedelicstockreview.com/mycotopia-therapies-tpia-signs-agreement-with-havn-life-sciences-havlf-for-purchase-of-psilocybin-spp/2021-09-22T13:31:14-04:00https://psychedelicstockreview.com/maxim-mental-health-and-psychedelic-conference/2021-09-22T14:20:15-04:00https://psychedelicstockreview.com/delic-delcf-to-acquire-ketamine-wellness-centers-inc-becoming-largest-psychedelic-wellness-chain-in-united-states/2021-09-24T06:24:54-04:00https://psychedelicstockreview.com/ehave-ehvvf-appoints-las-top-doc-dr-rahul-dixit-to-its-medical-advisory-board/2021-09-23T10:22:56-04:00https://psychedelicstockreview.com/americas-top-doc-bankole-johnson-joins-ehaves-ehvvf-medical-advisory-board/2021-09-23T10:55:44-04:00https://psychedelicstockreview.com/braxia-scientific-reports-q1-up-80-from-expanding-clinic-patient-base/2021-09-23T11:10:31-04:00https://psychedelicstockreview.com/three-psychedelic-presentations-available-now-filament-health-flhlf-novamind-nvmdf-and-wesana-health-wsnaf/2021-09-24T06:20:38-04:00https://psychedelicstockreview.com/report-ehave-inc-ehvvf-our-favorite-psychedelic-company/2021-09-24T14:47:59-04:00https://psychedelicstockreview.com/mindmed-mnmd-and-liechti-lab-provide-results-from-their-psilocybin-rd-collaboration/2021-09-24T10:34:06-04:00https://psychedelicstockreview.com/pharmather-cse-phrmannounces-cad10-million-private-placement-with-institutional-investors/2021-09-24T15:00:07-04:00https://psychedelicstockreview.com/delic-delcf-announces-c7-0-million-private-placement-with-institutional-investor/2021-09-24T15:19:43-04:00https://psychedelicstockreview.com/interview-ben-lightburn-ceo-of-filament-health-flhlf/2021-09-26T06:06:11-04:00https://psychedelicstockreview.com/interview-delic-wall-street-reporter/2021-09-26T11:01:02-04:00https://psychedelicstockreview.com/ehave-ehvvf-announces-inclusion-in-the-2021-psychedelic-investor-guide/2021-09-27T11:13:00-04:00https://psychedelicstockreview.com/conference-replay-of-advances-in-mental-health-m-vest-maxim-group-llc/2021-09-28T09:08:30-04:00https://psychedelicstockreview.com/interview-great-interview-with-cybin-cybn-ceo-doug-drysdale/2021-09-29T05:42:11-04:00https://psychedelicstockreview.com/ehave-ehvvf-announces-update-on-ehave-medical-app-with-the-launch-of-covid-vaccine-passport-going-live-shortly-2/2021-09-29T06:23:56-04:00https://psychedelicstockreview.com/psychedelic-stock-review-initiates-coverage-on-ehave/2021-10-04T14:59:37-04:00https://psychedelicstockreview.com/kcsa-psychedelics-conference-wednesday-october-13th/2021-10-12T15:49:31-04:00https://psychedelicstockreview.com/18-psychedelic-experts-presenting-bios/2021-10-13T06:43:22-04:00https://psychedelicstockreview.com/ehave-ehvvf-to-conduct-ketamine-clinical-trial-in-miami-florida/2021-10-14T09:35:53-04:00https://psychedelicstockreview.com/2021-guide-october/2023-05-08T15:46:22-04:00https://psychedelicstockreview.com/pasithea-therapeutics-ktta-opens-its-first-ketamine-therapy-clinic-in-the-united-kingdom/2021-10-15T10:06:27-04:00https://psychedelicstockreview.com/ketamine-testimonial-on-local-nashville-and-miami-news/2021-10-16T10:52:46-04:00https://psychedelicstockreview.com/private-post/2021-10-17T10:45:30-04:00https://psychedelicstockreview.com/2021-psychedelic-investor-guide-october/2021-12-18T07:50:34-05:00https://psychedelicstockreview.com/psychedelic-investor-tv/2021-10-18T11:03:52-04:00https://psychedelicstockreview.com/2021-psychedelic-investor-guide-released/2021-10-19T13:21:18-04:00https://psychedelicstockreview.com/psychedelic-therapeutics-sector-outlook-valhalla-ventures/2021-10-18T22:14:00-04:00https://psychedelicstockreview.com/psychedelic-drugs-far-exceed-cannabis-investment-potential-cnbc/2021-10-19T12:08:53-04:00https://psychedelicstockreview.com/ft-lauderdale-boat-show/2021-10-20T07:08:08-04:00https://psychedelicstockreview.com/mindcure-mcurf-and-awakn-life-sciences-awknf-seek-to-distribute-ketamine-protocol-for-alcohol-use-disorder/2021-10-28T15:34:15-04:00https://psychedelicstockreview.com/small-pharma-dmt-dmttf-0-46-a-small-and-extremely-interesting-psychedelic-company/2021-11-04T10:31:57-04:00https://psychedelicstockreview.com/coming-this-monday/2021-12-25T13:10:25-05:00https://psychedelicstockreview.com/mycotopia-therapies-tpia-issues-ceo-letter-to-stockholders-reports-on-significant-progress-and-outlook-for-2021/2021-11-06T09:15:39-04:00https://psychedelicstockreview.com/testimonial-the-ibogaine-clinic-playa-del-carmen/2021-12-25T13:07:03-05:00https://psychedelicstockreview.com/australian-icannex-ihlasx-headed-to-nasdaq/2022-02-11T06:20:23-05:00https://psychedelicstockreview.com/how-incannex-is-positioning-to-be-the-next-gw-pharma-with-ceo-joel-latham-stockhead/2022-02-11T06:47:35-05:00https://psychedelicstockreview.com/cybin-cybn-enters-into-collaboration-agreement-with-greenbrook-tms-gbnh-to-establish-mental-health-centers-of-excellence/2022-04-17T16:55:26-04:00https://psychedelicstockreview.com/ehave-inc-announces-its-ketadash-mobile-unit/2022-06-22T16:53:58-04:00https://psychedelicstockreview.com/pharmather-phrm-phrrf-gets-3-80-price-target-from-h-c-wainwright-37-times-3700-higher/2022-07-15T16:10:17-04:00https://psychedelicstockreview.com/stan-grof-psychedelics-elder-statesman/2022-08-17T05:37:02-04:00https://psychedelicstockreview.com/magic-mushroom-psychedelic-may-help-heavy-drinkers-quit-ap-news/2022-08-26T07:13:22-04:00https://psychedelicstockreview.com/silopharma-silo-attends-dawson-james-conference/2022-10-24T08:44:15-04:00https://psychedelicstockreview.com/stressed-wall-street-execs-flock-to-ketamine-therapy-sessions-ny-post/2023-09-08T07:13:12-04:00https://psychedelicstockreview.com/silo-pharma-silo-3-36-achieves-new-milestone-for-sp-26-therapeutic-initiates-ind-enabling-study-of-topical-ketamine-formulation/2022-11-11T13:10:37-05:00https://psychedelicstockreview.com/silo-pharma-silo-issues-letter-to-shareholders/2022-12-02T09:29:03-05:00https://psychedelicstockreview.com/awakn-life-sciences-awknf-0-30-announces-signing-of-lease-for-second-clinic-in-norway/2023-01-02T20:19:33-05:00https://psychedelicstockreview.com/the-kahner-global-cannabis-psychedelics-investment-summit/2023-02-15T10:37:03-05:00https://psychedelicstockreview.com/psycheceutical-to-conduct-the-first-ever-phase-i-and-ii-clinical-trials-of-a-novel-ketamine-topical-cream-to-treat-ptsd/2023-05-15T13:33:09-04:00https://psychedelicstockreview.com/is-atai-live-sciences-atai-2-17-finally-turning/2023-04-24T13:17:04-04:00https://psychedelicstockreview.com/johns-hopkins-receives-20m-from-roland-r-griffiths-ph-d-professorship-fund-for-psychedelic-research/2023-05-09T14:32:42-04:00https://psychedelicstockreview.com/ketamine-and-yale-university/2023-05-15T13:03:50-04:00https://psychedelicstockreview.com/adding-psycheceutical-bioscience-bwvi-0-14-to-watch-list-ketamine/2023-05-15T17:37:28-04:00https://psychedelicstockreview.com/shark-tanks-kevin-harrington-invests-in-psychedelics-company-psycheceutical-bwvi-forbes/2023-05-15T13:59:16-04:00https://psychedelicstockreview.com/psychedelic-marketing-from-steve-jobs/2023-05-24T08:13:50-04:00https://psychedelicstockreview.com/psychedelic-marketing-adrian-morrison/2023-09-08T07:41:40-04:00https://psychedelicstockreview.com/interview-dr-deborah-nash-ibogaine-and-miami-based-demerx/2023-06-04T07:56:51-04:00https://psychedelicstockreview.com/amanita-muscaria-in-a-vape/2023-09-08T07:12:02-04:00https://psychedelicstockreview.com/psyched-wellness-calm-now-available-at-locations-in-the-united-states/2023-09-08T07:34:50-04:00https://psychedelicstockreview.com/jordan-belfort-illegal-psychedelic-cured-my-addiction-and-opiate-cravings/2024-01-04T12:32:59-05:00https://psychedelicstockreview.com/zappy-zapolin-hopes-to-put-ibogaine-front-and-center-for-addiction/2023-10-09T12:30:00-04:00https://psychedelicstockreview.com/clearminds-cmnd-meai-and-reducing-alcohol-use/2023-10-29T08:50:36-04:00https://psychedelicstockreview.com/psychedelics-cured-my-alcoholism/2023-11-05T01:01:14-04:00https://psychedelicstockreview.com/seelos-falls-of-a-cliff-on-lesser-than-expected-results-in-patient-reduced-trial/2023-10-30T22:29:59-04:00https://psychedelicstockreview.com/psycheceutial-biosciences-bwvi-listed-on-wefunder/2023-11-01T09:55:33-04:00https://psychedelicstockreview.com/psychedelic-happy-hour-miami/2023-11-04T16:45:09-04:00https://psychedelicstockreview.com/psycheceuticals-bwvi-topical-ketamine-a-game-changer-for-ptsd/2024-01-04T16:53:08-05:00https://psychedelicstockreview.com/nrx-pharma-mrxp-presentation-at-sachs-neuroscience-forum/2024-01-20T16:42:30-05:00https://psychedelicstockreview.com/silo-pharma-silo-and-partner-receive-regulatory-approval-to-begin-development-of-ketamine-implant-for-fibromyalgia-a-3-1-billion-market/2024-01-20T21:46:01-05:00https://psychedelicstockreview.com/blake-mycoskie-pledging-100-million-to-psychedelic-research-marketwatch/2024-01-20T21:38:32-05:00https://psychedelicstockreview.com/atai-to-invest-50-million-in-beckley-psytech/2024-01-21T18:32:58-05:00https://psychedelicstockreview.com/veteran-navy-seal-advocates-for-psychedelic-assisted-therapy-interview-with-marcus-and-amber-capone-of-vets/2024-01-21T10:44:22-05:00https://psychedelicstockreview.com/psychedelic-support-team-the-fireside-project/2024-01-21T17:31:21-05:00https://psychedelicstockreview.com/free-psychedelic-help-is-just-a-call-or-text-away-fireside-project/2024-01-21T18:24:40-05:00https://psychedelicstockreview.com/lykos-therapeutics-formerly-maps-raises-100-million/2024-01-23T10:36:37-05:00https://psychedelicstockreview.com/helping-ketamine-clinics-succeed-beyond-marketing/2024-01-30T13:33:09-05:00https://psychedelicstockreview.com/guide-to-miami-hedge-fund-week-2024/2024-01-30T10:11:50-05:00https://psychedelicstockreview.com/non-hallucinogenic-psychedelics-and-short-term-vs-long-term-acting-psychedelics-whish-is-better/2024-01-30T14:42:06-05:00https://psychedelicstockreview.com/journey-medicals-1000-ketamine-therapist-are-available-24-7-interview-with-jonathan-sabbagh-ceo/2024-01-31T12:49:57-05:00https://psychedelicstockreview.com/startup-ketamine-clinic-being-health-raises-5-4-million/2024-01-30T18:27:21-05:00https://psychedelicstockreview.com/1000-days-without-alcohol-heres-what-happened/2024-02-07T13:15:29-05:00https://psychedelicstockreview.com/interview-clearmind-medicine-cmnd-ceo-adi-zuloff-shani-and-maps-founder-rick-doblin/2024-04-03T11:26:26-04:00https://psychedelicstockreview.com/compass-pathways-cmps-gets-a-beat-down-adding-to-2025-watch-list-2-36/2025-08-07T15:19:59-04:00https://psychedelicstockreview.com/400-million-man-tries-psychedelic-toads/2026-03-31T17:02:02-04:00https://psychedelicstockreview.com/mystery-solved-threshold-biosciences-neuroblo-ibogaine/2026-04-17T10:09:30-04:00